List of works - Christian Friedrich

A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetics of Empagliflozin and Linagliptin After Coadministration in Healthy Male Volunteers ⬇️

scientific article published on January 1, 2013

A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, in treatment of type 2 diabetes mellitus ⬇️

scientific article published on March 5, 2013

Absence of excretion of the active moiety of bisacodyl and sodium picosulfate into human breast milk: an open-label, parallel-group, multiple-dose study in healthy lactating women.

scientific article

Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying.

scientific article published on 5 June 2008

Clinical pharmacokinetics and pharmacodynamics of linagliptin.

scientific article

Comparable pharmacodynamics, efficacy, and safety of linagliptin 5 mg among Japanese, Asian and white patients with type 2 diabetes

scientific article published on 12 January 2016

Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.

scientific article published on July 2014

Effect of multiple oral doses of linagliptin on the steady-state pharmacokinetics of a combination oral contraceptive in healthy female adults: an open-label, two-period, fixed-sequence, multiple-dose study.

scientific article published in January 2011

In Vivo Formation of Ethinylestradiol After Intramuscular Administration of Norethisterone Enantate.

scientific article published on 9 March 2018

Letter to the editor regarding: "Pharmacokinetics of teneligliptin in subjects with renal impairment." Halabi et al., Clinical Pharmacology in Drug Development 2013;2:246-254.

scientific article published on 26 May 2014

Linagliptin fixed-dose combination with metformin is bioequivalent to co-administration of linagliptin and metformin as individual tablets

scientific article published on 01 July 2014

Pharmacokinetic and pharmacodynamic evaluation of linagliptin in African American patients with type 2 diabetes mellitus.

scientific article published on September 2013

Pharmacokinetics of single and multiple oral doses of 5 mg linagliptin in healthy Chinese volunteers

scientific article published on December 1, 2012

Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus.

scientific article published on July 2015

Population pharmacokinetic/pharmacodynamic analysis of the DPP-4 inhibitor linagliptin in Japanese patients with type 2 diabetes mellitus.

scientific article

Relative bioavailability of an empagliflozin 25-mg/linagliptin 5-mg fixed-dose combination tablet

Relative bioavailability study of linagliptin/metformin tablets in healthy Chinese subjects

scientific article published in July 2015

Renal impairment has no clinically relevant effect on the long-term exposure of linagliptin in patients with type 2 diabetes

scientific article published on 01 November 2013

List of works by Christian Friedrich

A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetics of Empagliflozin and Linagliptin After Coadministration in Healthy Male Volunteers ⬇️

A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, in treatment of type 2 diabetes mellitus ⬇️

Absence of excretion of the active moiety of bisacodyl and sodium picosulfate into human breast milk: an open-label, parallel-group, multiple-dose study in healthy lactating women.

Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying.

Clinical pharmacokinetics and pharmacodynamics of linagliptin.

Comparable pharmacodynamics, efficacy, and safety of linagliptin 5 mg among Japanese, Asian and white patients with type 2 diabetes

Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.

Effect of multiple oral doses of linagliptin on the steady-state pharmacokinetics of a combination oral contraceptive in healthy female adults: an open-label, two-period, fixed-sequence, multiple-dose study.

In Vivo Formation of Ethinylestradiol After Intramuscular Administration of Norethisterone Enantate.

Letter to the editor regarding: "Pharmacokinetics of teneligliptin in subjects with renal impairment." Halabi et al., Clinical Pharmacology in Drug Development 2013;2:246-254.

Linagliptin fixed-dose combination with metformin is bioequivalent to co-administration of linagliptin and metformin as individual tablets

Pharmacokinetic and pharmacodynamic evaluation of linagliptin in African American patients with type 2 diabetes mellitus.

Pharmacokinetics of single and multiple oral doses of 5 mg linagliptin in healthy Chinese volunteers

Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus.

Population pharmacokinetic/pharmacodynamic analysis of the DPP-4 inhibitor linagliptin in Japanese patients with type 2 diabetes mellitus.

Relative bioavailability of an empagliflozin 25-mg/linagliptin 5-mg fixed-dose combination tablet

Relative bioavailability study of linagliptin/metformin tablets in healthy Chinese subjects

Renal impairment has no clinically relevant effect on the long-term exposure of linagliptin in patients with type 2 diabetes